BioTime (BTX) Enters Exclusive Sublicense with Jade Therapeutics for HyStem Hydrogels

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KEYS
3. MRK
4. TGT
5. PANW
6. KLAR
7. LOW
8. UBER
9. SPY
10. MRVL

Go back to BioTime (BTX) Enters Exclusive Sublicense with Jade Therapeutics for HyStem Hydrogels
BIOTIME, Inc. (NYSE: BTX) Delayed: 8.88 --0 (-0%)
Previous Close $8.88    52 Week High $4.51 
Open $8.88    52 Week Low $2.02 
Day High $8.88    P/E N/A 
Day Low $8.88    EPS $-0.58 
Volume 3